Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/1996
06/25/1996US5529792 Homogenizing chicken embryo or adult bovine brain tissue, centrifuging, applying to cation exchanger, separating active fractions by gel filtration chromatography, purifying by reverse phase liquid chromatography
06/25/1996US5529780 Isolated nucleic acid coding for canine herpes virus glycoproteins
06/25/1996US5529776 Anti-HIV-1 neutralizing antibodies
06/25/1996US5529775 Compositions comprising ONCONASE(™) and cisplatin, melphalan, or doxorubicin HCl
06/24/1996CA2163159A1 Penicillin v amidohydrolase gene from fusarium oxysporum
06/24/1996CA2139065A1 Apoptosis specific tp30 protein
06/20/1996WO1996018745A1 Conserved yeast nucleic acid sequences
06/20/1996WO1996018741A2 Liposome-mediated transfection of central nervous system cells
06/20/1996WO1996018735A2 Tgf-beta superfamily type ii receptor having binding affinity for bone morphogenic protein (bmp)
06/20/1996WO1996018734A1 Production of recombinant secretory component
06/20/1996WO1996018730A1 Prostatic growth factor
06/20/1996WO1996018727A1 Adeno-associated derived vector systems for gene delivery and integration into target cells
06/20/1996WO1996018726A1 Compositions and methods for stimulating hematopoietic cell expansion
06/20/1996WO1996018725A1 Human tissue inhibitor of metalloproteinase-4
06/20/1996WO1996018654A1 Factor vii fragment 82-128 and its use in blood-clotting disorders
06/20/1996WO1996018651A1 Human somatostatin-like receptor
06/20/1996WO1996018650A1 Novel receptor
06/20/1996WO1996018649A1 Improved cyclic crf agonists
06/20/1996WO1996018648A1 Superagonists and antagonists of h il-6, and 3d modelling method for their selection
06/20/1996WO1996018647A1 Spray dried erythropoietin
06/20/1996WO1996018646A2 Heat shock protein peptides and methods for modulating autoimmune central nervous system disease
06/20/1996WO1996018642A1 Amino acids for making betides and methods of screening and making betide libraries
06/20/1996WO1996018641A1 Modulators of the function of fas/apo1 receptors
06/20/1996WO1996018417A1 Crystalline protein controlled release compositions
06/20/1996WO1996018414A1 Acellular anti-bordetella vaccine
06/20/1996WO1996018412A1 Chimeric cytokines and uses thereof
06/20/1996WO1996018409A1 In vivo activation of tumor-specific cytotoxic t cells
06/20/1996WO1996018390A1 Delivery of nucleic acid molecules to mucosal tissue
06/20/1996WO1996012809A3 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens
06/20/1996WO1996012018A3 Novel immunophilins and corresponding nucleic acids
06/20/1996DE4444753A1 Prodn. of casein-alpha-s2 peptide(s) with antibiotic activity
06/20/1996CA2207921A1 Novel receptor
06/20/1996CA2207816A1 Conserved yeast nucleic acid sequences
06/20/1996CA2207736A1 In vivo activation of tumor-specific cytotoxic t cells
06/20/1996CA2207576A1 Improved cyclic crf agonists
06/20/1996CA2206669A1 Human tissue inhibitor of metalloproteinase-4
06/20/1996CA2206258A1 Amino acids for making betides and methods of screening and making betide libraries
06/20/1996CA2206244A1 Adeno-associated derived vector systems for gene delivery and integration into target cells
06/20/1996CA2205572A1 Chimeric cytokines and uses thereof
06/20/1996CA2177838A1 A methodology for selecting superagonists, antagonists and superantagonists of human interleukin-6 based on receptor complex three dimensional modelling
06/19/1996EP0717110A1 LGMD gene
06/19/1996EP0717109A1 Synthetic DNA derived recombinant HIV-2 antigens
06/19/1996EP0717108A1 Recombinant prrs proteins, diagnostic kits and vaccines containing said recombinant proteins
06/19/1996EP0717107A1 Transformant line of candida utilis yeast and expression of heterogene therewith
06/19/1996EP0717106A1 Immunogenic hybrid protein OprF-Oprl derived from Pseudomonas aeruginosa membrane proteins
06/19/1996EP0717105A2 Genomic DNA fragments cooling for the beta2-subunit of the neuronal nicotinic acetylcholine receptor; transgenic animals containing it
06/19/1996EP0717104A2 Immunoassay of non-A, non-B hepatitis virus-related antigens, monoclonal antibodies for use therein, and hybridomas producing the antibodies
06/19/1996EP0717049A1 Process for the extraction and purification of alfa1-antitrypsin (alfa1-pI) from cohn IV-1 fraction
06/19/1996EP0716713A1 Compositions and methods for detecting target nucleic acid sequences utilizing adjacent sequence-enzyme molecules
06/19/1996EP0716711A1 Vector for gene therapy of the liver
06/19/1996EP0716710A1 Methods of suppressing immune response by gene therapy
06/19/1996EP0716709A1 Enhanced expression in plants using non-translated leader sequences
06/19/1996EP0716707A1 Promoters
06/19/1996EP0716705A1 Method for the recombinant preparation of proteins in hansenula yeast
06/19/1996EP0716704A1 MULTIPLE INTEGRATIVE VECTORS AND $i(YARROWIA LIPOLYTICA) TRANSFORMANTS
06/19/1996EP0716703A1 Glycophorin binding protein (gbp130) fusion compositions
06/19/1996EP0716701A1 Cloning of a member of the serine-threonine-kinase family
06/19/1996EP0716700A1 Models of alzheimer's disease
06/19/1996EP0716697A1 DIFFERENTIALLY EXPRESSED $i(LEISHMANIA) GENES AND PROTEINS
06/19/1996EP0716696A1 Uses of myelin oligodendrocyte glycoprotein and peptide portions thereof in protocols related to autoimmune disease
06/19/1996EP0716695A1 Human calcium channel compositions and methods using them
06/19/1996EP0716694A1 Human glucagon-like 1 peptide receptor
06/19/1996EP0716692A1 Methods of suppressing autoimmune response
06/19/1996EP0716691A1 Methods of suppressing graft rejection
06/19/1996EP0716662A1 Dna encoding prostaglandin receptor ep2
06/19/1996EP0716660A1 MUTANTS OF THE Rb AND p53 GENES AND USES THEREOF
06/19/1996EP0716659A1 Epiligrin, an epithelial ligand for integrins
06/19/1996EP0716609A1 METHODS AND COMPOSITIONS FOR STIMULATING AND INHIBITING TGF-$g(b) ACTIVITY
06/19/1996EP0716591A1 METHODS AND COMPOSITIONS FOR BINDING TAU AND MAP2c PROTEINS
06/19/1996EP0621899B1 Expression signal-peptide-free staphylokinases
06/19/1996EP0527778B1 Improved process of purifying recombinant proteins and compounds useful in such process
06/19/1996EP0524173B1 Solubilization and purification of the gastrin releasing peptide receptor
06/19/1996EP0516851B1 Physiologically active substance well capable of permeating biomembrane
06/19/1996EP0506923B1 A collagen binding protein as well as its preparation
06/19/1996EP0495852B1 Modified biological material
06/19/1996EP0489089B1 Therapeutic peptides
06/19/1996EP0452484B1 Production of proteins using homologous recombination
06/19/1996EP0424397B1 Calcium channel compositions and methods
06/19/1996EP0418310B1 Gene for encoding a human malaria vaccine antigen
06/19/1996CN1124978A Cell matrix stimulated cell attachment and hemidesmosome assembly
06/19/1996CN1124964A Trifunctional antithrombin and antiplatelet peptides
06/19/1996CN1124929A Novel agent for controlling cell activity
06/19/1996CN1124927A Analogs of peptide YY and uses thereof
06/19/1996CN1124779A Method of diagnosing cancer, precancerous state, or susceptibility to other forms of diseases by analysis of IRF-1-spectific RNA in biopsy samples
06/18/1996USRE35277 Cell membrane proteins, compositions containing them and procedure for their preparation
06/18/1996US5527901 Tetrasaccharides bonding to a label, a chromatograpic support or protective group for isolating, purifying antibodies
06/18/1996US5527897 Genetic engineering
06/18/1996US5527896 Cloning by complementation and related processes
06/18/1996US5527894 From contacting nucleic acid mixture with hiv-1 tat protein; partitioning, amplification
06/18/1996US5527884 Mediators of chronic allograft rejection and DNA molecules encoding them
06/18/1996US5527883 Delta-endotoxin expression in pseudomonas fluorescens
06/18/1996US5527882 Polypeptide having an amino acid replaced with N-benzylglycine
06/18/1996US5527881 Procedure for preparing salmon calcitonin
06/18/1996US5527856 Method of preparing crosslinked biomaterial compositions for use in tissue augmentation
06/18/1996US5527777 Peptide compounds, in particular LHRH-antagonists
06/18/1996US5527776 Treatment of immunologic and hematologic disorders with IGFBP alone or complexed with IGF
06/18/1996US5527775 Reduction of mammalian neoplasms with phospholipase A2 activating substances
06/18/1996US5527773 Use of synthetic peptides to disrupt the cytoskeleton
06/18/1996US5527772 Regulation of cell proliferation and differentiation using peptides
06/18/1996US5527770 Immunotherapeutic agent derived from bacteria
1 ... 2539 2540 2541 2542 2543 2544 2545 2546 2547 2548 2549 2550 2551 2552 2553 2554 2555 2556 2557 2558 2559 ... 2916